BIOGEN CHESAPEAKE LLC has a total of 43 patent applications. It decreased the IP activity by 81.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Republic of Korea and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and measurement are DA VOLTERRA, ARBORVITAE HEALTH AND WELLBEING PTY LTD and US WORLDMEDS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Republic of Korea | 6 | |
#3 | Australia | 5 | |
#4 | Canada | 5 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | China | 2 | |
#8 | Brazil | 1 | |
#9 | Israel | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Biotechnology | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Analysing materials | |
#5 | Electrotherapy | |
#6 | Enzymes | |
#7 | Unspecified technologies | |
#8 | Microorganisms | |
#9 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Jacobson Sven | 20 |
#2 | Jacobson Sven Martin | 19 |
#3 | Macallister Thomas | 14 |
#4 | Ang Robert | 4 |
#5 | Simard J Marc | 2 |
#6 | Sven Martin Jacobson | 2 |
#7 | Clarke Gillian | 1 |
#8 | Elkins Jacob | 1 |
#9 | Matharu Rajinder | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020223436A1 | Method for treating subjects suffering from central nervous system contusions | |
CN109689037A | Utilize the medical therapy of SUR1-TRPM4 channel inhibitor | |
US2019167611A1 | Methods of treating or preventing amyloid related imaging abnormalities associated with alzheimer's disease treatment | |
AU2016271576A1 | Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells | |
US2014080811A1 | Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels | |
EP3586850A1 | Methods of intravenous administration of glyburide and other drugs |